Sign in

CIK 0001520262

  • Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981007018
Phone
+353 17728000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$697,937
in 4 filings, $698K under 10b5-1 plans

Net −$697,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-02-21 Gaffin David Joseph SVP, CLO, Alkermes, Inc. Exercise or conversion +6,875 59,362
2020-02-21 Gaffin David Joseph SVP, CLO, Alkermes, Inc. Shares withheld for taxes −2,016 $20.24 $41K 57,346
2020-02-21 Gaffin David Joseph SVP, CLO, Alkermes, Inc. Exercise or conversion · Restricted Stock Unit Award −6,875 20,625
2020-02-21 FRATES JAMES M SVP, Alks Inc; CFO ALKS Exercise or conversion +5,825 68,380
2020-02-21 FRATES JAMES M SVP, Alks Inc; CFO ALKS Shares withheld for taxes −1,712 $20.24 $35K 66,668
2020-02-21 FRATES JAMES M SVP, Alks Inc; CFO ALKS Exercise or conversion · Restricted Stock Unit Award −5,825 17,475
2020-02-21 Brown Iain Michael SVP Finance & CAO, Alks Inc. Exercise or conversion +4,800 38,384
2020-02-21 Brown Iain Michael SVP Finance & CAO, Alks Inc. Shares withheld for taxes −1,391 $20.24 $28K 36,993
2020-02-21 Brown Iain Michael SVP Finance & CAO, Alks Inc. Exercise or conversion · Restricted Stock Unit Award −4,800 14,400
2020-02-20 POPS RICHARD F Director and CEO, Alkermes plc Grant or award · Employee Stock Option (Right to Buy) +358,466 358,466
2020-02-20 LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. Grant or award · Employee Stock Option (Right to Buy) +89,545 89,545
2020-02-20 LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. Grant or award · Restricted Stock Unit Award +21,415 21,415
2020-02-20 Hopkinson Craig C. EVP R&D, Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +168,856 168,856
2020-02-20 Hopkinson Craig C. EVP R&D, Chief Medical Officer Grant or award · Restricted Stock Unit Award +40,382 40,382
2020-02-20 Gaffin David Joseph SVP, CLO, Alkermes, Inc. Grant or award · Employee Stock Option (Right to Buy) +117,688 117,688
2020-02-20 Gaffin David Joseph SVP, CLO, Alkermes, Inc. Grant or award · Restricted Stock Unit Award +28,145 28,145
2020-02-20 FRATES JAMES M SVP, Alks Inc; CFO ALKS Grant or award · Employee Stock Option (Right to Buy) +102,337 102,337
2020-02-20 FRATES JAMES M SVP, Alks Inc; CFO ALKS Grant or award · Restricted Stock Unit Award +24,474 24,474
2020-02-20 Brown Iain Michael SVP Finance & CAO, Alks Inc. Grant or award · Employee Stock Option (Right to Buy) +76,753 76,753
2020-02-20 Brown Iain Michael SVP Finance & CAO, Alks Inc. Grant or award · Restricted Stock Unit Award +18,356 18,356

Page 76 of 90 · 1,796 trades